daily californian logo

BERKELEY'S NEWS • SEPTEMBER 30, 2023

Apply to The Daily Californian by September 8th!
tag

Jacob Corn

Page 1 of 1

The breakthrough gene-editing technology CRISPR-Cas9, which was co-discovered by UC Berkeley professor of biochemistry and molecular biology Jennifer Doudna, may soon be applied to humans for the first time to treat sickle cell disease.
featured article
The breakthrough gene-editing technology CRISPR-Cas9, which was co-discovered by UC Berkeley professor of biochemistry and molecular biology Jennifer Doudna, may soon be applied to humans for the first time to treat sickle cell disease.
featured article
Two UC Berkeley assistant professors were each awarded with $1.5 million in grants for their innovative contributions to cell research Thursday.
featured article
Two UC Berkeley assistant professors were each awarded with $1.5 million in grants for their innovative contributions to cell research Thursday.
featured article
UC Berkeley researchers have developed an improved method for gene-editing in mice that will allow for more efficient and accessible genetic modeling.
featured article
UC Berkeley researchers have developed an improved method for gene-editing in mice that will allow for more efficient and accessible genetic modeling.
featured article
Building on groundbreaking research in gene therapy released by UC Berkeley scientists, Bay Area researchers will work to push the boundaries of genetic engineering in a new collaboration between UC Berkeley and UC San Francisco.
Building on groundbreaking research in gene therapy released by UC Berkeley scientists, Bay Area researchers will work to push the boundaries of genetic engineering in a new collaboration between UC Berkeley and UC San Francisco.